Skip to main content
logo
InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.290
-0.020 (-1.53%)
Sep 11, 2026, 4:00 PM EDT - Market closed

InMed Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-12.56-8.16-7.68-7.95-18.6
Depreciation & Amortization
0.710.530.60.60.51
Loss (Gain) From Sale of Assets
0.01---0.01
Asset Writedown & Restructuring Costs
1.65---3.47
Stock-Based Compensation
0.110.120.140.280.78
Provision & Write-off of Bad Debts
-0-0.05-
Other Operating Activities
0.010.080.320.311.32
Change in Accounts Receivable
--0.11-0.09-0.22-0.04
Change in Inventory
-0.280.070.57-2
Change in Accounts Payable
0.62-0.250.05-0.81-0.81
Change in Other Net Operating Assets
-0.69-0.26-0.39-0.11-0.22
Operating Cash Flow
-8.64-7.77-6.99-7.28-15.58
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
---0.01-0.16-0.04
Cash Acquisitions
----0.5-0.21
Investing Cash Flow
---0.01-0.66-0.67

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Short-Term Debt Repaid
-----0.29
Total Debt Repaid
-----0.29
Net Debt Issued (Repaid)
-----0.29
Issuance of Common Stock
0.238.135.2210.6817.15
Other Financing Activities
-0.144.14-0.56--1.78
Financing Cash Flow
0.0912.274.6510.6815.07

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash Flow
-8.554.5-2.342.74-1.19

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-8.64-7.77-7-7.45-15.62
Free Cash Flow Growth
-----
Free Cash Flow Margin
--157.14%-152.14%-180.02%-1434.03%
Free Cash Flow Per Share
-2.08-7.96-18.36-60.81-557.14
Levered Free Cash Flow
-3.63-4.45-4.02-4.81-8.87
Unlevered Free Cash Flow
-3.62-4.22-4.02-4.81-8.87

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Income Tax Paid
--0.01--
Change in Working Capital
-0.08-0.34-0.37-0.57-3.07
SEC Filings: 10-K · 10-Q